| Trial registration number
|
NCT04751604 |
Full text link
Last imported at : Feb. 16, 2021, 12:31 a.m.
Source : ClinicalTrials.gov
|
https://clinicaltrials.gov/show/NCT04751604
|
First author
Last imported at : May 7, 2022, 5 a.m.
Source : ClinicalTrials.gov
|
Stefan Schreiber
|
Contact
Last imported at : May 7, 2022, 5 a.m.
Source : ClinicalTrials.gov
|
Not reported
|
Registration date
Last imported at : Feb. 16, 2021, 12:31 a.m.
Source : ClinicalTrials.gov
|
2021-02-12
|
Recruitment status
Last imported at : Nov. 9, 2022, 4 p.m.
Source : ClinicalTrials.gov
|
Completed
|
Study design
Last imported at : Feb. 16, 2021, 12:31 a.m.
Source : ClinicalTrials.gov
|
RCT
|
Allocation
Last imported at : Feb. 16, 2021, 12:31 a.m.
Source : ClinicalTrials.gov
|
Randomized
|
Design
Last imported at : Feb. 16, 2021, 12:31 a.m.
Source : ClinicalTrials.gov
|
Parallel
|
Masking
Last imported at : Feb. 16, 2021, 12:31 a.m.
Source : ClinicalTrials.gov
|
Blind label
|
Center
Last imported at : March 15, 2023, 4 a.m.
Source : ClinicalTrials.gov
|
single-center
|
Study aim
Last imported at : Feb. 16, 2021, 12:31 a.m.
Source : ClinicalTrials.gov
|
Treatment
|
Inclusion criteria
Last imported at : Aug. 23, 2021, 7 p.m.
Source : ClinicalTrials.gov
|
inclusion criteria:
- the patient is of age (at least 18 years).
- sars-cov-2 infection confirmed by laboratory findings; the positive test must not date
back more than 7 days.
- relevant infection symptoms, e.g. in the respiratory or gastrointestinal tract.
- the patient has been able to give written consent via a website before any trial
procedure is performed and can comply with the trial-dependent prerequisites and
requirements.
|
Exclusion criteria
Last imported at : May 7, 2022, 5 a.m.
Source : ClinicalTrials.gov
|
current participation in another trial.
pregnancy or breastfeeding.
vaccination against sars-cov-2.
|
Number of arms
Last imported at : Feb. 16, 2021, 12:31 a.m.
Source : ClinicalTrials.gov
|
2
|
Funding
Last imported at : Feb. 16, 2021, 12:31 a.m.
Source : ClinicalTrials.gov
|
University Hospital Schleswig-Holstein
|
Inclusion age min
Last imported at : Feb. 16, 2021, 12:31 a.m.
Source : ClinicalTrials.gov
|
18
|
Inclusion age max
Last imported at : Feb. 16, 2021, 12:31 a.m.
Source : ClinicalTrials.gov
|
100
|
Countries
Last imported at : Feb. 16, 2021, 12:31 a.m.
Source : ClinicalTrials.gov
|
Germany
|
Type of patients
Last imported at : Feb. 16, 2021, 12:31 a.m.
Source : ClinicalTrials.gov
|
No restriction on type of patients
|
Severity scale
Last imported at : Feb. 16, 2021, 12:31 a.m.
Source : ClinicalTrials.gov
|
0: No restriction on type of patients
|
Total sample size
Last imported at : May 7, 2022, 5 a.m.
Source : ClinicalTrials.gov
|
900
|
primary outcome
Last imported at : May 7, 2022, 5 a.m.
Source : ClinicalTrials.gov
|
Frequencies of individual COVID-19 symptoms at week 0, week 2 (primary time of analysis), week 4 and week 6 as well as after 6 months.
|
Notes
Last imported at : Feb. 16, 2021, 12:31 a.m.
Source : ClinicalTrials.gov
|
None
|
Phase
Last imported at : Nov. 16, 2021, 6:30 p.m.
Source : ClinicalTrials.gov
|
Not reported
|
Arms
Last imported at : Feb. 16, 2021, 12:31 a.m.
Source : ClinicalTrials.gov
|
[{"arm_notes": "", "treatment_id": 885, "treatment_name": "Nicotinamide", "treatment_type": "Nutrition", "pharmacological_treatment": "Non pharmacological treatment"}, {"arm_notes": "", "treatment_id": 2187, "treatment_name": "Placebo", "treatment_type": "Placebo", "pharmacological_treatment": "Placebo"}]
|